# Sana Biotechnology: Biotechnology, Seattle, United States

> Sana Biotechnology: Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients. Based in Seattle, United States.

Source: https://millionrounds.com/startup/sana-biotechnology (Millionrounds; every figure on the page links to its filing or article)

United States · [Biotechnology startup](https://millionrounds.com/companies)

# Sana Biotechnology

Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.

Funding reported Last round: Post ipo equity

Biotechnology Seattle, United States

Company summary

- **Founded:** 2018 8 years old
- **Team:** 251 201 to 1,000 people
- **Funding reported:** $865M in dollars
- **Last round:** Post ipo equity Feb 2024

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Sana Biotechnology has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## What company datasets say Sana Biotechnology raised

Funding, as reported

Reported in all **$865M** in dollars

Rounds **4**

Last round **Post ipo equity**

Last round date **Feb 2024**

Investors listed **13**

SEC Form D **$867M sold, 2 filings, last Jun 2020**

## Founders and team

From Sana Biotechnology's own website and the SEC filings it signed: 7 on the team.

- **Aaron Grossman** Executive Vice President, Chief Legal Officer
- **Debra Wisdom** Vice President, Head of People
- **Rob Rosiello** Director
- **Hans J. Bishop** Chairman
- **James J. MacDonald** Executive Officer i
- **Nathan D. Hardy** Executive Officer i
- **Steven D. Harr** Executive Officer, Director i

On the board, as filed i *Donald J. Payan* *Douglas J. Cole* *Geoffrey J. von Maltzahn* *Mary Agnes J. Wilderotter* *Patrick J. Yang* *Richard J. Mulligan* *Robert J. Nelsen* *Stephen J. Knight*

## On 4 portfolio pages

Investors who name them

- [T1D Fund](https://millionrounds.com/fund/t1d-fund)
- [ARCH Venture Partners](https://millionrounds.com/fund/arch-venture-partners)
- [Innovating Capital](https://millionrounds.com/fund/innovating-capital)
- [City Hill Ventures](https://millionrounds.com/fund/city-hill-ventures)

Each firm lists Sana Biotechnology on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## Biotechnology in United States

Startups like it

- [**Sojournix** Waltham · founded 2016 *Raised*](https://millionrounds.com/company/sojournix)
- [**Receptor Life Sciences** Seattle · founded 2017 *Raised*](https://millionrounds.com/company/receptor-life-sciences)
- [**Attune Pharmaceuticals** New York · founded 2018 *Raised*](https://millionrounds.com/company/attune-pharmaceuticals)
- [**AbbVie** North Chicago · founded 2012](https://millionrounds.com/startup/abbvie-2)
- [**Grail** Menlo Park · founded 2015](https://millionrounds.com/startup/grail-3)
- [**EQRx** Cambridge · founded 2019](https://millionrounds.com/startup/eqrx)
- [**Cerevel Therapeutics** Boston · founded 2018](https://millionrounds.com/startup/cerevel-therapeutics)
- [**Royalty Pharma** New York · founded 1996](https://millionrounds.com/startup/royalty-pharma)

## Is this your company?

Add your raise, your deck and your story, and put Sana Biotechnology in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)